NCT02434666View on ClinicalTrials.gov

Long Term Extension Safety Study in Patients With Dementia of the Alzheimer's Type Who Completed Study CPC-001-07

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 8, 2015

Primary Completion Date

October 18, 2016

Study Completion Date

November 22, 2016

Conditions

Dementia of the Alzheimer's Type

Interventions

DRUG

CPC-201

Trial Locations (5)

27103

Giles Cromwell, MD, Winston-Salem

33064

Quantum Laboratories, Inc. Memory Disorder Center, Pompano Beach

33137

Miami Jewish Health Systems, Miami

33407

Premiere Research Institute Neuroscience, West Palm Beach

46202

IU School of Medicine IU Health Neuroscience Center, Indianapolis

All Listed Sponsors

lead

Chase Pharmaceuticals Corporation, an affiliate of Allergan plc

INDUSTRY

NCT02434666 - Long Term Extension Safety Study in Patients With Dementia of the Alzheimer's Type Who Completed Study CPC-001-07 | Biotech Hunter | Biotech Hunter